PEOPLE - University of Edinburgh announces directorship of the National Creutzfeldt-Jakob Disease surveillance unit:
This article was originally published in Clinica
The University of Edinburgh has announced that James Ironside has assumed directorship of the National Creutzfeldt-Jakob Disease surveillance unit. Professor Ironside's appointment is in accordance with recent management restructuring plans, whereby directorship of the unit must be rotated amongst the key management members. The other participants in the three-year tenure rotation scheme are fellow consultant neurologists Robert Will, who was director since the founding of the unit in 1990, and Richard Knight, who has been appointed to the newly-created position of deputy director.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.